SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-130534
Filing Date
2023-05-01
Accepted
2023-05-01 16:30:51
Documents
10
Period of Report
2023-06-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d488212ddef14a.htm DEF 14A 519978
2 GRAPHIC g488212g00a03.jpg GRAPHIC 37687
3 GRAPHIC g488212g23x61.jpg GRAPHIC 1101
4 GRAPHIC g488212g26y42.jpg GRAPHIC 1072
5 GRAPHIC g488212g27n94.jpg GRAPHIC 1536
6 GRAPHIC g488212g50w33.jpg GRAPHIC 1357
7 GRAPHIC g488212g63a89.jpg GRAPHIC 2198
8 GRAPHIC g488212g64s50.jpg GRAPHIC 1306
9 GRAPHIC g488212g76k04.jpg GRAPHIC 1027
10 GRAPHIC g488212g86m49.jpg GRAPHIC 928
  Complete submission text file 0001193125-23-130534.txt   588816
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39756 | Film No.: 23874206
SIC: 2834 Pharmaceutical Preparations